Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Baxter
Merck
Dow
McKinsey

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Litigation Details for Endo Pharmaceuticals Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2011)

See Plans and Pricing

« Back to Dashboard

Endo Pharmaceuticals Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2011)

Docket   Start Trial Date Filed 2011-08-16
Court District Court, D. Delaware Date Terminated 2014-06-20
Cause 35:271 Patent Infringement Assigned To Renee Marie Bumb
Jury Demand None Referred To Karen M. Williams
Parties ENDO PHARMACEUTICALS INC.; MATRIX LABORATORIES INC.; MATRIX LABORATORIES LIMITED; MYLAN INC.; MYLAN PHARMACEUTICALS INC.
Patents 5,464,864; 5,616,603; 5,637,611; 5,827,871; 5,962,501
Attorneys Arnold Calmann; Bindu Ann George Palapura; David Ellis Moore; Douglas Carsten; Elham F. Steiner; Jack B. Blumenfeld; Jeffrey Soos; Jeremy A. Tigan; Julia Heaney; Katherine A. Escanlar; Katherine J. Van Gunst; Matthew J. Bresnahan; Nicole W. Stafford; Richard L. Horwitz; Tung-On Kong; Yongdan Li
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Endo Pharmaceuticals Inc. v. Mylan Pharmaceuticals Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Endo Pharmaceuticals Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-08-16 1 Complaint : 5 PATENTS-IN-SUIT U.S. Patent No. 5,464,864 24. On November 7, 1995, the United States Patent and …infringement of U.S. Patent Nos. 5,464,864; 5,637,611; and 5,827,871 (collectively, the “Patents-in-Suit”) arising…Office duly and legally issued U.S. Patent No. 5,464,864 (“the ’864 Patent”), entitled “Use of Tetrahydrocarbazole… the ‘864 Patent is attached hereto as Exhibit A. 25. The ‘864 Patent was granted a Patent Term Extension… the ‘864 patent pursuant to an assignment from Vernalis Development Limited. U.S. Patent No. 5,637, External link to document
2011-09-30 11 infringement of U.S. Patent Nos. 5,464,864; 5,637,611; and 5,827,871 (collectively, the “Patents-in-Suit”) pursuant…2011 20 June 2014 1:11-cv-00717 830 Patent None District Court, D. Delaware External link to document
2011-10-04 12 infringement of U.S. Patent Nos. 5,464,864; 5,637,611; and 5,827,871 (collectively, the “Patents-in-Suit”) pursuant…2011 20 June 2014 1:11-cv-00717 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Dow
McKesson
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.